FLUENT Completes Acquisition of RIV Capital, Adding New York Retail, Wholesale and Cultivation Operations to its Multi-State Footprint Accelerates FLUENT’s entry into one of the
TransCon hGH is marketed in the US as SKYTROFA for paediatric GHD. Credit: Drazen Zigic via Shutterstock. Ascendis Pharma has submitted a supplemental biologics licence
Merck KGaA is revamping its R&D efforts as it increases focus on licensing deals rather than its internal pipeline. Several months after a Phase III